ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 43 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonora Investment Management, LLC | 17,307,000 | $17,094,989,000 | 2.72% |
| STEELHEAD PARTNERS LLC | 30,000,000 | $29,745,000 | 2.45% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 25,097,000 | $25,027,000 | 1.58% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 45,700,000 | $45,283,000 | 1.57% |
| Jabre Capital Partners S.A. | 4,500,000 | $4,458,000 | 0.96% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 48,598,000 | $48,198,000 | 0.95% |
| SSI INVESTMENT MANAGEMENT LLC | 11,606,000 | $11,468,000 | 0.93% |
| Verition Fund Management LLC | 10,025,000 | $9,942,000 | 0.74% |
| LINDEN ADVISORS LP | 31,259,000 | $30,992,000 | 0.74% |
| WOLVERINE ASSET MANAGEMENT LLC | 42,644,000 | $42,343,000 | 0.55% |